ArticleBMJ open respiratory research2026
Long-term variability of impulse oscillometry defined small airway dysfunction in participants with and without chronic obstructive pulmonary disease.
Article in BMJ open respiratory research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSmall airway dysfunction (SAD), as assessed by impulse oscillometry (IOS) (IOS-SAD), exhibits temporal variability and its long-term fluctuations may be linked to distinct clinical phenotypes. We investigated the associations of long-term variability in IOS-SAD with adverse clinical outcomes among participants with and without chronic obstructive pulmonary disease (COPD).
methodsThe baseline and 2-year follow-up data from the early COPD cohort were retrospectively analysed. SAD was defined based on the following criteria: difference from R5 to R20 (R5-R20) >upper limit of normal (ULN) (R5-R20-SAD), or reactance at 5 Hz (X5) <lower limits of normal, or area under the reactance curve (AX) >ULN. Individuals were classified into three groups based on SAD variability over three visits at 2-year follow-up: (1) consistent SAD (SAD at every visit), (2) inconsistent SAD (SAD at some, but not all, visits) and (3) never SAD (no SAD at any visit). Differences in the rate of spirometric lung function decline and exacerbation rate were compared across long-term IOS-SAD variability groups in participants with and without COPD.
resultsIn individuals with COPD, the consistent and inconsistent SAD groups assessed were associated with a faster spirometric lung function decline and a higher risk of exacerbations. In individuals without COPD, the consistent R5-R20-SAD group was associated with a faster decline in spirometric lung function and progression towards COPD.
conclusionsSAD, even diagnosed once, characterises an airway behaviour with a higher proportion of higher risk of moderate or severe exacerbations. Consistent SAD was associated with accelerated spirometric lung function decline, increased exacerbation risk and progression to spirometry-defined COPD. TRIAL REGISTRATION NUMBER: ChiCTR1900024643.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.